original article Wien Klin Wochenschr (2017) 129:879–892 DOI 10.1007/s00508-017-1248-1 Management and clinical outcome of stable coronary artery disease in Austria Results from 5 years of the CLARIFY registry Irene M. Lang · Roza Badr-Eslam · Nicola Greenlaw · Robin Young · Philippe Gabriel Steg Received: 23 April 2017 / Accepted: 30 July 2017 / Published online: 14 September 2017 © The Author(s) 2017. This article is an open access publication. Summary were enrolled between November 2009 and July 2010 Background The population of patients with estab- and observed until September 2015. lished coronary artery disease (CAD) is growing be- Results The primary risk factors in Austrian out- cause of an improvement in outcomes and survival patients with stable CAD were smoking (current from acute disease episodes. Nevertheless, these pa- smokers: 13.2%), overweight (77.1%), hypertension tients remain at high risk of cardiovascular events. (78.5%), raised low-density lipoprotein (LDL) choles- Thus, CAD management is important in prevention terol plasma levels (81.4% ≥ 0.7 g/l or 1.8 mmol/l), of disease progression. The objective of this analysis elevated heart rate (≥70 bpm: 60.9% in patients was to describe disease management and clinical out- with anginal symptoms) and poor physical activity come of Austrian
Wiener klinische Wochenschrift – Springer Journals
Published: Sep 14, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera